• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康婴儿血浆瘦素、瘦素可溶性受体及其摩尔比的发育变化

Developmental variations in plasma leptin, leptin soluble receptor and their molar ratio in healthy infants.

作者信息

Koo Winston W K, Hammami Mouhanad, Hockman Elaine M

机构信息

The Carman and Ann Adams Department of Pediatrics, Wayne State University and Hutzel Hospital, Wayne State University, Detroit, Michigan, USA.

出版信息

Nutr J. 2007 Jun 4;6:11. doi: 10.1186/1475-2891-6-11.

DOI:10.1186/1475-2891-6-11
PMID:17547758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1894811/
Abstract

BACKGROUND

Leptin and its soluble receptor (sOB-R) are important to regulation of body composition but there are no data on the developmental variations in these plasma variables and their relationship with body composition measurements,

METHODS

Weight, length, and body composition (bone, fat and lean mass) by dual energy absorptiometry, and plasma variables were measured in healthy infants at 2, 4, 8 and 12 months.

RESULTS

15 whites and 29 African Americans (21 males and 23 females) with mean birth weight 3357 +/- 45 (SEM) g and gestation of 39.3 +/- 0.17 weeks were studied. The overall Z score for weight, length and weight for length during the study were 0.00 +/- 0.15, -0.08 +/- 0.11 and 0.12 +/- 0.14 respectively. With increasing age, plasma leptin (1.0 to 18.2, median 5.5 ng/mL) and sOB-R:leptin molar ratio (10.1 to 247.4, median 59.9) were lowered (r = -0.47, p < 0.01; and r = -0.37, p < 0.05 respectively), best predicted by weight Z score and percentage of fat mass, and higher in African American and female. Presence of body composition measurements eliminated the race and gender effect on the plasma variables. Plasma sOB-R (49.5 to 173.9, median 81.3 ng/mL) did not change significantly with age and was correlated and predicted only by body composition measurements.

CONCLUSION

In healthy growing infants, plasma leptin but not sOB-R decreases with age. Gender, race and anthropometric measurements are additional physiological determinants predictive of plasma leptin and the receptor:ligand ratio. However, body composition is the only variable that can predict plasma leptin and its soluble receptor and the receptor: ligand ratio; and body composition measurements eliminated the race and gender effect on these plasma variables.

摘要

背景

瘦素及其可溶性受体(sOB-R)对身体成分的调节很重要,但关于这些血浆变量的发育变化及其与身体成分测量值之间的关系尚无数据。

方法

对健康婴儿在2、4、8和12个月时测量体重、身长、通过双能吸收法测量身体成分(骨骼、脂肪和瘦体重)以及血浆变量。

结果

研究了15名白人婴儿和29名非裔美国婴儿(21名男性和23名女性),平均出生体重3357±45(SEM)克,妊娠39.3±0.17周。研究期间体重、身长和身长别体重的总体Z评分分别为0.00±0.15、-0.08±0.11和0.12±0.14。随着年龄增长,血浆瘦素(1.0至18.2,中位数5.5 ng/mL)和sOB-R:瘦素摩尔比(10.1至247.4,中位数59.9)降低(r分别为-0.47,p<0.01;r为-0.37,p<0.05),最佳预测指标是体重Z评分和脂肪量百分比,且在非裔美国人和女性中更高。身体成分测量值的存在消除了种族和性别对血浆变量的影响。血浆sOB-R(49.5至173.9,中位数81.3 ng/mL)随年龄无显著变化,仅与身体成分测量值相关且可由其预测。

结论

在健康成长的婴儿中,血浆瘦素随年龄降低,而sOB-R则不然。性别、种族和人体测量指标是预测血浆瘦素及其受体:配体比值的额外生理决定因素。然而,身体成分是唯一能够预测血浆瘦素及其可溶性受体以及受体:配体比值的变量;并且身体成分测量值消除了种族和性别对这些血浆变量的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37d/1894811/8e7e35a70d50/1475-2891-6-11-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37d/1894811/2990d4526a9f/1475-2891-6-11-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37d/1894811/8e7e35a70d50/1475-2891-6-11-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37d/1894811/2990d4526a9f/1475-2891-6-11-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b37d/1894811/8e7e35a70d50/1475-2891-6-11-2.jpg

相似文献

1
Developmental variations in plasma leptin, leptin soluble receptor and their molar ratio in healthy infants.健康婴儿血浆瘦素、瘦素可溶性受体及其摩尔比的发育变化
Nutr J. 2007 Jun 4;6:11. doi: 10.1186/1475-2891-6-11.
2
Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition.终末期肾病中的可溶性瘦素受体与血清瘦素:与炎症和身体成分的关系
Eur J Clin Invest. 2002 Nov;32(11):811-7. doi: 10.1046/j.1365-2362.2002.01063.x.
3
Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.健康人群体内脂肪量和常量营养素摄入量与循环可溶性瘦素受体、游离瘦素指数、脂联素及抵抗素浓度的关系
J Clin Endocrinol Metab. 2003 Apr;88(4):1730-6. doi: 10.1210/jc.2002-021604.
4
Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity.神经性厌食症少女及对照人群中可溶性瘦素受体、瘦素和游离瘦素指数的激素及身体成分预测因素及其与胰岛素敏感性的关系
J Clin Endocrinol Metab. 2004 Jul;89(7):3486-95. doi: 10.1210/jc.2003-032251.
5
Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence.儿童期、青春期及青少年期的循环可溶性瘦素受体与游离瘦素指数
J Clin Endocrinol Metab. 2002 Oct;87(10):4587-94. doi: 10.1210/jc.2002-020001.
6
Decreased soluble leptin receptor levels in women with polycystic ovary syndrome.多囊卵巢综合征女性可溶性瘦素受体水平降低。
Eur J Endocrinol. 2006 Feb;154(2):287-94. doi: 10.1530/eje.1.02078.
7
Inverse changes in the serum levels of the soluble leptin receptor and leptin in neonates: relations to anthropometric data.
J Clin Endocrinol Metab. 2005 Apr;90(4):2212-7. doi: 10.1210/jc.2004-1454. Epub 2005 Jan 25.
8
Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin.体重减轻会增加可溶性瘦素受体水平以及瘦素的可溶性受体结合部分。
Obes Res. 2002 Jul;10(7):597-601. doi: 10.1038/oby.2002.81.
9
Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.丙戊酸治疗对癫痫儿童身体成分、瘦素及可溶性瘦素受体的影响。
Epilepsy Res. 2008 Aug;80(2-3):142-9. doi: 10.1016/j.eplepsyres.2008.03.017. Epub 2008 May 9.
10
Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome.代谢综合征中的可溶性瘦素受体及瘦素的可溶性受体结合部分
Obes Res. 2003 Jun;11(6):760-8. doi: 10.1038/oby.2003.106.

引用本文的文献

1
Racial variation in umbilical cord blood leptin concentration in male babies.男婴脐带血瘦素浓度的种族差异。
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):665-71. doi: 10.1158/1055-9965.EPI-10-0283. Epub 2011 Feb 9.

本文引用的文献

1
Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification.瘦素在软骨内成骨过程中调节软骨细胞分化和基质成熟。
Bone. 2005 Nov;37(5):607-21. doi: 10.1016/j.bone.2005.05.009. Epub 2005 Jul 20.
2
Developmental changes in leptin as a measure of energy status in human infants in a natural ecologic setting.
Am J Clin Nutr. 2005 Feb;81(2):488-94. doi: 10.1093/ajcn.81.2.488.
3
Appetite control.食欲控制
J Endocrinol. 2005 Feb;184(2):291-318. doi: 10.1677/joe.1.05866.
4
Inverse changes in the serum levels of the soluble leptin receptor and leptin in neonates: relations to anthropometric data.
J Clin Endocrinol Metab. 2005 Apr;90(4):2212-7. doi: 10.1210/jc.2004-1454. Epub 2005 Jan 25.
5
Serum leptin levels of premature and full-term newborns in early infancy: metabolic catch-up of premature babies.早期婴儿期早产儿和足月儿的血清瘦素水平:早产儿的代谢追赶
Turk J Pediatr. 2004 Jul-Sep;46(3):232-8.
6
Technical considerations for fan-beam dual-energy x-ray absorptiometry body composition measurements in pediatric studies.儿科研究中扇形束双能X线吸收法测量身体成分的技术考量
JPEN J Parenter Enteral Nutr. 2004 Sep-Oct;28(5):328-33. doi: 10.1177/0148607104028005328.
7
Dual energy X-ray absorptiometry measurements in small subjects: conditions affecting clinical measurements.小受试者的双能X线吸收测定法:影响临床测量的条件
J Am Coll Nutr. 2004 Jun;23(3):212-9. doi: 10.1080/07315724.2004.10719363.
8
Body composition of neonates from fan beam dual energy X-ray absorptiometry measurement.扇形束双能X线吸收测定法测量新生儿的身体成分。
JPEN J Parenter Enteral Nutr. 2003 Nov-Dec;27(6):423-6. doi: 10.1177/0148607103027006423.
9
Fan beam dual energy X-ray absorptiometry body composition measurements in piglets.仔猪的扇形束双能X线吸收法体成分测量
J Am Coll Nutr. 2003 Oct;22(5):408-14. doi: 10.1080/07315724.2003.10719324.
10
A nearly continuous measure of birth weight for gestational age using a United States national reference.使用美国国家参考标准对孕周出生体重进行近乎连续的测量。
BMC Pediatr. 2003 Jul 8;3:6. doi: 10.1186/1471-2431-3-6.